December 22, 2022Hospira, Inc. Issues A Voluntary Nationwide Recall For One Lot of Vancomycin Hydrochloride Injection, USP 1.5g/vial, Due To The Presence of Visible Glass Particulates December 22, 2022 - Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Vancomycin
December 22, 2022Lunsumio approval from FDA for treatment of adults with relapsed or refractory follicular lymphoma December 22, 2022 - Genentech, a member of the Roche Group, has announced that the U.S. Food and Drug Administration
December 22, 2022Sunlenca approved by FDA for use with other antiretrovirals for the treatment of HIV-1 infections December 22, 2022 - Gilead Sciences, Inc. has announced that Sunlenca ® (lenacapavir), in combination with other antiretroviral(s)
December 22, 2022NexoBrid (anacaulase-bcdb) approved for the Treatment of Severe Thermal Burns in Adults December 29, 2022 - MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation biotherapeutic
December 21, 2022Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Four Lots of Quinapril Tablets Due to Potential Presence of N-Nitroso-Quinapril Impurity December 21, 2022 - Lupin Pharmaceuticals Inc. is voluntarily recalling four (4) lots of Quinapril Tablets
December 21, 2022Newly Approved Indications December 21, 2022 - The FDA approved a new indication for Actemra (tocilizumab) injection (PDF, 2.6 MB) for the treatment of hospitalized adult patients with COVID-19 who are receiving systemic
December 20, 2022FDA Approves Tymlos as a Treatment to Increase Bone Density in Men withOsteoporosis at High Risk for Fracture December 20, 2022 – Radius Health, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved Tymlos
December 19, 2022FDA Approves Indication for Pemfexy in Combination with Pembrolizumab andPlatinum Chemotherapy December 19, 2022 - Eagle Pharmaceuticals, Inc announced today that the U.S. Food and Drug Administration has approved an additional